PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 2004The Journal of Clinical Endocrinology & Metabolism1,553 citationsOpen Access

Medical Consequences of Obesity

View Full Paper
GBGeorge A. Bray

Key Points

  • To delineate the mechanical and metabolic pathways through which excess adipose tissue leads to systemic morbidity and reduced life expectancy.
  • Narrative synthesis of clinical and biological mechanisms connecting adipose tissue expansion to disease pathogenesis.
  • Classification of obesity complications into physical mass-induced dysfunctions versus secretory and metabolic cellular effects.
  • Excess physical fat mass directly contributes to osteoarthritis from joint wear, sleep apnea via parapharyngeal deposition, and severe psychosocial stigma.
  • Enlarged adipocyte secretions—including free fatty acids, interleukin-6, and prothrombin activator inhibitor-1—trigger hepatic insulin resistance, systemic inflammation, endothelial dysfunction, and elevated diabetes and cardiovascular risks.
  • Adipose stromal production of estrogens and proliferative cytokines increases susceptibility to hormone-sensitive and proliferative malignancies, ultimately shortening life expectancy.

Abstract

Obesity is an epidemic disease that threatens to inundate health care resources by increasing the incidence of diabetes, heart disease, hypertension, and cancer. These effects of obesity result from two factors: the increased mass of adipose tissue and the increased secretion of pathogenetic products from enlarged fat cells. This concept of the pathogenesis of obesity as a disease allows an easy division of disadvantages of obesity into those produced by the mass of fat and those produced by the metabolic effects of fat cells. In the former category are the social disabilities resulting from the stigma associated with obesity, sleep apnea that results in part from increased parapharyngeal fat deposits, and osteoarthritis resulting from the wear and tear on joints from carrying an increased mass of fat. The second category includes the metabolic factors associated with distant effects of products released from enlarged fat cells. The insulin-resistant state that is so common in obesity probably reflects the effects of increased release of fatty acids from fat cells that are then stored in the liver or muscle. When the secretory capacity of the pancreas is overwhelmed by battling insulin resistance, diabetes develops. The strong association of increased fat, especially visceral fat, with diabetes makes this consequence particularly ominous for health care costs. The release of cytokines, particularly IL-6, from the fat cell may stimulate the proinflammatory state that characterizes obesity. The increased secretion of prothrombin activator inhibitor-1 from fat cells may play a role in the procoagulant state of obesity and, along with changes in endothelial function, may be responsible for the increased risk of cardiovascular disease and hypertension. For cancer, the production of estrogens by the enlarged stromal mass plays a role in the risk for breast cancer. Increased cytokine release may play a role in other forms of proliferative growth. The combined effect of these pathogenetic consequences of increased fat stores is an increased risk of shortened life expectancy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

George A. Bray (2004) studied this question.

synapsesocial.com/papers/6a10c47339dd87f6d0ee4d62https://doi.org/10.1210/jc.2004-0535
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Visceral obesity and breast cancer risk1994 · 159 citations
  2. 2Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin2002 · 19,162 citations
  3. 3Obesity and Knee Osteoarthritis1988 · 1,067 citations
  4. 4Energy Metabolism in Obesity: Studies in the Pima Indians1993 · 71 citations
  5. 5Obesity and Gallbladder Disease2003 · 1 citations